Search Results 2441-2450 of 110913 for Cells

1. SeungBaek Lee, Ph.D. - Mayo Clinic Faculty Profiles

   ... cells (TECs), tumor-associated macrophage, circulating tumor cells (CTCs) and extracellular matrix (ECM). Mitosis — mitotic checkpoint and nuclear envelope ...

2. Stomach Cancer Clinical Trials - Mayo Clinic Research

   ... cells to grow and spread. Chemotherapy and radiation therapy may reduce the tumor size and the amount of normal tissue that needs to be removed during ...

3. Tumor Invasion and Metastasis - Department of Cancer Biology - Mayo Clinic Research

   Analysis of cancer cell migration. The Brain Tumor Stem Cell Research Laboratory of Alfredo Quinones-Hinojosa, M.D., uses patient-derived cancerous cells ...

4. Safety and Efficacy of ALLO-605 an Anti-BCMA Allogeneic CAR T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   The purpose of the ALLO-605-201 study is to assess the safety, effectiveness, and cell kinetics of ALLO605 in adults with relapsed or refractory multiple ...

5. A Study of MPDL3280A (Anti-PD-L1 Antibody) Combined with Carboplatin and Paclitaxel , and with or without Bevacizumab, for Patients who have Stage IV Non-Squamous Non-Small Cell Lung Cancer - Mayo Clinic

   ... Cell Lung Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab ...

6. A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung Cancer that has Returned or is Resistant to Treatment - Mayo Clinic

   A Study to Assess the Effectiveness, Safety, and Drug/Body Interactions of Rovalpituzumab for Third-Line and Later Treatment of Patients with Small Cell Lung ...

7. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

   A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients ... cell carcinoma (vhRCC), a type of kidney ...

8. Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma - Mayo Clinic

   Study Comparing CB-839 with Cabozantinib vs. Cabozantinib with Placebo in Patients with Metastatic Renal Cell Carcinoma · Share · Facebook · Twitter.

9. A Year of Discovery: 10 Mayo Clinic research breakthroughs moving medicine forward

   Immunofluorescent image of immune cells in tissues affected by giant cell arteritis. Mayo Clinic researchers have found that some older people maintain "immune ...

10. David J. DiCaudo, M.D. - Mayo Clinic Faculty Profiles

    DiCaudo collaborates with colleagues in studies focused on the diagnosis and treatment of cutaneous T-cell and B-cell lymphomas. Skin cancers. Dr. DiCaudo ...